Atdmugh there have been significant advance in the care of many of the extrapancmatic manifestations of diabetes, acute myacerdial infarction continues to be a major cause nf morbidily and mortality in diabetic palients. Factors unique to diabetes increase stberosclerotic plaque fm'mation and thrombosis, thereby contributlng to myaeardial infarction. Autonomic nsurapllby may predispose ta infsrrtion and result in atypical prsspnting symp twm in the diabetic patisnt, making diagnosis difficult and fr&a& complicated and csrriw a highs; mwtsltty rate in the diabetic than in the nondiabetic patient. Althawh the course and pnthophysialagy of myocardial h&lion d&r to some degree in diabetic patients from tbw in patients without diabetes, much more remalm to be knnwn to fmmulate more effsctivo treatment rlrntegirs in this high risk subgroup.
Incidenw and extent of coronary artery d&se. Diabetes is ac independem risk factor for the development of corenary artery disease (6). The overall prevalence of coronary disease, as assessed by various diagnostic methods, is as high BS 55% among adult patients with diabetes compared with '2% to 4% for the general population (6). Comnary atherosclerosis is not only more prevalent, it is also ciearly more extensive in diabetic than in nondiabetic patients (7). At coronary angiogmphy or autopsy, patients with diabetes have a higher incidence of double-and triple-vessel disease and a lower incidence of single-vessel disease than those of their nondiabetic counterparts (68). The incidence of severe left main coronary disease is also significantly higher (13% vs. 6%) in diabetic than in nondiabetic patients (9). In one large autopsy study, Yl% of patients with adult onset diabetes and no known coronary heart disease had severe narrowisg of at least one majorcoronay srtery and 63% had severe Iflo-or three-vessel involvement (9). In a group of adtdts of similar age without overt diabetes or known coronary heart disease, only 33% had severe single-vessel coronary nuxwving and 17% had severe two-or three-vessel disease at autopsy (IO). Whether coronary atherosclerosis is actually more "diffuse" or is merely expressed as a greater number of discrete stenoses is the subject of some debate (9,l I). In the autopsy study mentioned, diabetic patients who dsed of coronary artery disease had more sknoses than did nondiato be a risk factor for atherogenesis. Hypnnculinernia even betic patients but the appearance of other arterial segments in the pre~enc-If normal glucose tolerance is associated was similar between the two groups. However. another with an increase m risk factors for coronary artery disease autopsy study found that patients with juvenile onset diabeincluding low HDL cholesterol levels and hypertension (22). tes had a more diffuse fortn of coronary artery disease with Hypcrmsulinemia may also play a role in promoting atheroat least half of the overall lenglh of the epicatdial coronary stierobts by causing smooth muscle celi proliferatwn and arteries narrowed by ~50% whereas in nondiabetic oatients cholesterol synthesis and by increasing levels of growth <I% of the length was similarly involved (12).
hormone (23). Hyp@ycemia atone has been suggested as a risk factor for athciosclerosis. though the level of hyperglycemia itself is not an indeoendent risk factor for the devel-
Factors Favoring Myocardial Infarction in
Patients With Diabetes opment of co~onaty artery disease.
Patients wnh diabetes have elevated plasma and whole blood viscosity due to high levels of plasma proteins and Acute infarction most often involves in!errup:ion of myoincreased red cell aggregation and possibly decreased red cardial blood Row due to underlying atherosclerotic plaque cell deformability (24.25). These effects are particularly with further lumen compromise by thmmbus (13). Pmgresevident during periods of metabolic derangement such as sion of atherosclerosis may occur through repeated plaque diabetic ketnacidosis and appear to be improved with better rupture and thrombosis in a repetitive cycle of injury and glycemic control. Increased shear forces due to high vixoshealing that results in lumen narrowing (14). Diabetes is ity could enhance a tendency toward plaque rupture. In associated with an increased propensity for both atheroscleaddition. these rheologic effects could contribute to infarct rotic plaque formation and intraluminal thrombosis. which extension by impeding collateral coronary blood flow, permay increase the likelihood of infarction.
titularly in areas with low blood Row at baseline. Aeeekrated athercsderosis and plnqw rupture. Elevated serum lipid levels induce vascular damage and promote athemsckmsis. Pathologic studies of coronary vessels in patients after infarction indicate that lipid-rich plaques may be more likely to rupture than fibrous plaques (14). Compared with persons without diabetes, patients with diabetes or hypertension, or both, appear to have a greater number of such fissured plaques (15). Despite a prepondernnce of lipid abnormalities in patients with diabetes, the independent contribution of total cholestetnl to coronary artery disease is approximately the same as that in patients without diabetes (16). The average total cholesterol level in the Framingham study was 245 mg/dl and similar in patients with and without diabetes (17). Patients with diabetes have higher levels of very low density lipoprotein cholesterol WLDL) and trialycet'& and lower levels of high density lipoprotein tf?DL) cholesterol than do patients without diabetes, whereas levels of total and low density lipoprotein (LDL) cholesteml are not substantially different between the two groups (IS). The sfgnit?cance of the diabetic patient's altered lipid prog:e as it relates to risk of coronary artery disease has not yet been defined.
Hemat&sgfe sbnomtelii 6weebsg comnaq thrombosis. Occlusive thrombus formation is likely a dynamic process that depends on a balance between those factors that favor clotting and those that oppose it. In diabetes, abnomudities relating to platelet function, coagulation. fibrinolyris and endothelial function have been described that may favor intraluminal thrombosis at the site of plaque fissurina or rUpUU.E.
Platelet aggregation is an essential step in wclusive thrombus fortnation. Recently, spontaneous platelet aggre@ion has been shown to predict recurrent infarctinn after myocardial infarction (26). Spontaneous and induced platelet aaaregatian have been shown to be higher in patients with f27-3& than in patients without diabetes and correlate with so increase in cardiovascular events (27). Diabetic platelets seem to synthesize thmmhoxane As in ahnormally high amounts ml-341. a findina that would favor nlatelet aanre@ion and vascuku spa& Elevated thrntnb& h&are mnst often found in diabetic p&tents with poor gfycemic control or vascular complications (29). Platelet consumption is higher in diabetic padents (29) and two platelet-specific pmteins, beta-thromboglobulin and platelet factor4, thought to reflect in viva pk&let activation, may be elevated in these patients W29k
As mentioned, hypertension has been associated with an increased tendency toward plaque fissuring. a major precursor to myocardial infarction (IS) and hypertension is more common~in diabetic lhan in nondiabetic patients (16). It is found in Ml% of diabetic mtieni~ .45 years of ace (16X Its prevalence is especially high in diabedc want& and is a tiequent accompaniment to diabetic nephropathy. Cardiovascular morndfty in diabetic nephropetby is up to 37 times that of the general population, probably at least in part because of the associated hypertension (19-7.1).
Iiyperinsulinemia, particularly conunon in noninsulindependent diabetes mellitus with insulin resistance, appears
The time of onset of acute ayocardia: infarction in diabetic and non&&tic p&ents has been shown to parallel the circadian variation in platelet reactivity in these patients. Whereas the population et large exhibits a prominent darning increase in onset of Q wax infarction coincident .witb their period of greatest platelet agaregability (35). among diabetic patients Q wave infarction may occur more evenly throughout the day (3Sa). Platelet reactivity in diabetic patients has been shown to be elevated consistently throughout the day (361, an observation supporting the hypothesis that thls heightened platelet reactivity may have a causative mle in the increased iwdcncc of myocardial infarctloo in patients with diabetes.
Plasma fibrinogen levels are elevated in diabetic patients (29,37) and have been shown to correla!e with myocardial infarcuor and sudden death in diabetic men (27). Factor VIII and factor VU1 ristocetin rofactor antigen are elevated in diabetic patients as well (25,27,29). Flbrinopeptide A reflects in viva thrombin activity and may also be elevated m diabelic patien:s (X.29,38). Endothelial dysfunction or damage in patients with diabetes results in deficient production of prostacyclin (29,39-41) and elevated levels of the procoagulanr van Willebmnd factor (25,27,29). Endogenous fibrinolysis has also been found to be deficient in these patients (29.37,38).
Metabolic factors. Numerous studies have examined the relation of type of therapy for diabetes to both the extent of coronary artery disease and Ihc ouwxne after acute myocardial infarction. The majority of these studies indicate that treatment with oral hypoglycemic agents or insulin is wociated with a poorer prognosis (42-47) and more extensive coronary disease than those of diabetes controlled by diet alone (48.49). Elevated clvcosvlated hemoelobin levels. which reftect inadequate l&&m glycemic;ontrol, have also been shown to be associated with a higher mortality rate after infarction (46). Despite the evidence that poor long term glycemic control is associated with a negative outcome. no study has convincingly demonstrated that improved glycemic control leads to better clinical outcome.
Role of aulonomic neuropathy. The development af symptomatic autonomic neuropathy in diabetic patients is associated wth a mortality late-of up to 50% 3 ye& after its onset (501. Sudden, possibly cardiac. death is resoonsible for up to 33% of thesk deathi (SO). Cardiac p&ympathetic nerve fibers are affected before sympathetic fibers, leading initially to a relative increase in sympathetic tone that results in tachycardia at rest and attenuation of the expected increase in heart rate and blood pressure with exercise (5 I ,52). An absence ofparasympathetic tone may also be responsible for exaggerated or inappropriate coronary vasoconstriction. which may produce or wouen ischemia. Sympathetic nervow system dysfunction is usually evident within 5 years of the diagnosis of parasympathetic dysfunction. The principal clinical manifestation of sympathetic dvsfunction is oostural hypotension. Autonomic oeiropathy thus may lead'to ischemia or infarction by several routes: increasing myacardial oxygen demand by increasing heart late at rest, reducing myocardial blood flow by inricaaing 'rronary vascular tone at the site of a coronary stenosir, re!lucing coronary perfusion pressure during onhostatic hypotension (53) and climinatinr: early warning signs of ischemia.
Autonomic neuroporky and morbidiry during general onerrhesia. The importance of intact autonomic function during cardiovascul& stress (a3 in a myocardial infarction) is exemplified in diabetic patients undergoing general anesthesia. Burgos et al. 154) found that 35% of diabetic patients compared with onlv 5% of nondiabetic patients required vasopressor suppon tp < 0.05). The increased morbidity in diabetic patients experiencing general anesthesia may be due to inability to counteract the hemodynamic effects of induction of anesthesia because of impaired cardiovascular reflexes (54). Diabetic patients who required vasopressor soppon had significantly greater autonomic impairment than did those patients who did not.
Auronomic nerrrooarkv and sadden death. In addition, autonomic neuropatiy miy be responsible for sudden death in diabetic oatients (55-591. Althoueh some of these sudden deaths ma; be due to arrhythmia secondary to a silent myocardial infarction, autopsy studies have demonstrated a surprising absence of significant coronary artery disease in some diabetic patients experiencing sudden death (56,60). A relation has been noted between diabetic cardiac autonomic neuropathy and prolonged QT interval on the electrocardiogram (ECG) (57-59.61). which may predispose to lifeethreatening ventricular arrhythmia. Diabetic patients with autonomic neuropathy have been found to have a relative decrease in vagal tone (thus a relative increase in sympathetic tone) at the same time of day when the frequency of sudden death has been ranted 10 be uarticularlv hieh (62). It has been proposed that the combination oi reiatively heightened sympathetic tone or QT interval txolotwation. or both, might increase the likelihood of arrhythmias leading to sudden death (61.62).
Altered perception of iahemia. Diabetic patients have a blunted appreciation for ischemic pain. As a result of this reduced sensation, myocardial ischemia or infarction may be associated with only mild symptoms and go unrecognized or may be entirty asymptomatic and thus truly silent. Althcdgh 25% of the myocardial infarctions in the Framingham study were unrecognized, symptoms referable to infarction could be elicited in nearly 50% ofthese cases. The remaining infarctions (or approximately 12% of the total number) were believed to be truly asymplomatic. Unrecognized infarction tends to be more common in diabetic patients (63). and comprises 39% of their infarctions compared with 22% of those in nondiabetic patients (64). Although there has beena general trend towrd a higher prevalence of silent infarction in diabetic patients, conclusive proof of this pixnomenon has been hindered by the limited statistical power of most studies. These data parallel the observation that myocardiat scar in the absence of an antemonem history of infarction is three times more commonly found at autopsy in diabetic than in nondiabetic patients (65).
As might he inferred from the preceding data, diabetic paticnts may also lack angina duiug myucardial ischemia. The incfdence of painless ST depression during exercise tolerance tests is almost double that seen in nondiabetic padents (69% vs. 35%) and is related to severe autonomic neuropathy (66). Nesto et al. (67) demonstrated that diabetic patients experience angina less commonly than do nondiabetic patients during ischemia on thallium exercise testing.
Diabetic patients who do experience angina become aware of their symptoms later in the coarse of ischemia than do nondiabetic patients 1681. 'The delay m tone from the onset of ST segment depression to angina may be twice as long m diabetic as in nondiabetic p&en& and care&, wLi rho extent of autonomic nervous dysfunction (681. Neuropathy of &rent autonomic pathways may also indicate damage to a&rent autonomic fibers responsible for the transmwion of sensory impulses relating to perceptton of myocardial ischemia. Histologic damage to cardiac &rent nerve fibers 1691. as well as physiologic evidence of afferent and efferent nerve damage (55,70.7lL has been shown in diabetic pauents. suggesting that neuropathy involving these fibers exist, and may play a role in blunting ischemic pain.
Role of aiypicsl presenting symptoms. The diabeuc patient's abnormal perception of myocardial ischemia may lead to atypical or less impressive symptoon of myocardial infarction than are seen in the nondiabetic patient. Accurate diagnosis of infarction based on historical grounds may therefore be difficult. Atypical symproms such as confusion. dyspnea. fatigue ornaoseaand vomiting may be the presenrine camolaint in 32% to 42% of diabetic oatients with myocard~al infarction compared with 6% to 15% of nondiabetic patients (72). In some cases such symptoms may mim:c those associated with either hypoglycemia or hyperglyce. mia. which can cause delay in triaging the patient. The atypical presenting symptoms seen in the diabetic patient may lower the clinician's suspicion of infxc:ion. 'eadinp to les; than optimal care. Sole; et al. (43) found that 357; of diabetic patients with acute rnyocardial infarction were admitted initially to the general wards rather than to the coronary care unit. More than 75% of those diabetic patients assigned to ward care lacked typical chest pain. whereas nearly all of those admitted to the coronary care unit had severe chest pain. A comwiron of the ECG at mesentation with a prior tking may tk extremely helpful in~establishing a diagnosis when a patient with suspected acute myocardial infarction has no typical symptoms.
Atypical symptoms may alter the patients' perception of the nature of their illness and interfere with their decision to seek medical care. An association has been noted between nonpainful myocwdij ;/ idrctice and iscreased zrdiac morbidity and mortality (73.74). Uretsky et al. (73) examined a group of diabetic and nondiabetic patients in whom acute myoardial infarction was associated with atypical symptoms. These patients were older than patients with more classic symptoms and most had no history of prior angina.
They did not seek medical care until a mean of I2 h after the onset of symptoms and ~33% waited ~-24 h. Cardiogcnic shock was seen in 35% of patients with atypical presenting symptoms and the hospital mortality rote was 50% It seems likely that the delay in receiving appropriate care may contribute to the observed increase in morbidity and mor-
Course of Acute Myocardial Inarction
In the immediate peri-infarction period. moTtality is cspecidly high in diabetic patients. In one study 175). :he In-howlal mortality rate of diabetic oatienrs expaiencinc a mvocardial infarction was 28%. Tbi-rate was 18% in [h&e w!~h a host mfarction but increzscd substantially to 418 in thovz with a prior infarction. Approximately 5a of patients presenting with acute myocardial infarction have previously undiagnoxd diabetes mellitus. These patients share the poor prognoses of the previously diR:-?sed diabetic patients with acute mfarcrion (46). Diabetic women have a poorer prognosis than do diabetic men and newly twice the in hospital mortality rate (75). In one study 176) the increxed mortality seen in women was attnbuted to their high incidence of severe congestive heart failure and cardiogenic shock. The etiology of the increased frequency of co&stive heart failure did shock among women is not kown. Obese diabetic women may be at particular risk: this group had an in-hospital moriality rate of 43% in one study (77).
In contrast to younger patients without diabetes. who gcncrally seem to tolerate infarction better than the elderly, younger diabetic patients constitute a particularly high risk group: Czyzk et al. (78) found that diabetic patients between the ages of 45 and M years have a particularly increased mortality rate compared with that of nondiabetic patients of similar age with acute myocardial infarction. Singer and colleagues 17Y) also found that younger diabetic patients with a low baseline risk profile had the greatest relative mortality risk fmm myocardial infarction.
Complications of infarction. Diabetic patients sustaining a myocardial infarction are more likely than nandiabetic patients to encounter complications. Recurrent infarction, cardiogenic shock, atrioventtiular and intraventricolar conduction abnormalities. chronic congestwe heart failure and myocardial rupture are all more common in the diabetic than in the nondiabetic patient (44.45.78,80,81). In sddition. some studies have found anterior infarction to be more common l45.79.82). and this may partially explain their overall poorer prognosis. Anterior transmural myocardial infarction in one study was associated with a 46% 3@day mortality rate in diabetic patients (79).
in oider studies. clinically significant (class 111 or IV) congestive heartfailure develbpedin4l%ofdiabetic women and 25% of diabetic men (75) and was believed 10 be the cause of death in 22% ofdiabetic women and 6% of diabetic men with acute myocardial infarction (75). The increased incidence of congestive failure in patients with diabetes, and in dlabetlc worn&t in particular, is seen even though infxt size is similar in patients with and without diabetes (76). This increase in congestive heart failure ofcurs even though diabetic and nondiabetic patients also have similar valoes for left ventricular ejection fraction (45). Several factors inay be responsible for these observations. Diabetic patients are likely to have antecedent hypertension, which may Impair systohc or diastolic function, or both. The presence of autonomic dysfunction may also impair reflex adaptation to hemodynamic stress imposed by infarction. The greater extent of coronary artery disease in the diabetic patient mi&t also limit the availability of collateral blood Row to the infarct zone, thus unpairing some of the functional recovery atforded by restored blood Row to the infarcl zone.
Diabetic cardiomyopathy. Congestwe heart fatlure out of proportion to myocardial infarct size could also be due in part to eoneomitant subclinrcal diabetic cardiomyoplby Because diabetic cardiomyopathy occurs in the absence of coronary disease, it is unlikely that it is directly involved in the pathogenesis of acute or recurrent myocardial infuretion in diabetic patients. Diabetic cardiomyopathy may indirectly predispose to myocardial infarction by increasing wall tension secondary to myocardial dilation or by further impairing myocaniial perfuston at the n~icrovascuiar level in a r&n distal to an epicardial coronary stenosis or occlusion. Acute myocardial infarction supetimposed on a substrate of preexisting diabetic cardiomyopathy may then further increase w: II stress and contribute too more morbid enurse after infarction.
Diabetic ntc'abuliem and outcome after infarction. In addition, metabolic responses to iscbemia peculiar to the diabetic patients could affect contractile performance. Under conditions of myocardial ischcmia, glycemic control becomes particularly importam. During ischcmia the heart shifts from aerobic metabolism with Primary use of fatty acids to anaerobic metabolism, which depends on glucose as an energy source. Glucose transport into cells is therefore crucial. Insulin favors glucose uptake, whereas ketones, high levels of free fatty acids and their oxidation producls. found during insulinopenia, inhibn its transmembrane movemen!. Catecholamine excess, often present with infarction, may further worsen myocardial metabolism in the diabetic patient by decreasing insulin secretory reserve and favoring lipolyhis and myocardial free fatty acid uptake. There is smte evidence that free fatty acids may be toxic to myocardial cells (95) . Studies have shown that elevated plasma glucose levels during myocardial infarction may be associated with a nom outcome after mfarction (43,44,46). These da:a roust be interpreted with caution because hyperglycemia or diabetic ketoacidosis may be the result of increased adrenergic tone due to more extensive infarction. Diabetic kelnacidosis occurs in approximately 4% of infarctions in diabetic patients (75) and may be the presenting symptom. When diabetic kctoacidosis complicates infarction, mortality is higher and may approach 85% (96).
Major risk fuetors. The increased in-hospital mortality rete in diabetic patitnt~ with infarction in one study was found to occur durina davs 2 to 7 of the hosoital stav. Durine this period the mort&y~rate was more than three timer that of nondiabetic patients and was seen mostly prominenlly in patients with insulin-dependent diabetes (78). Much of the excess mortality during this interval was due to congestive heart failure. although arrhythmias and condur_tian abnormalities were sinnificant contributors as well. In this studv. diabetic patientswith arrhythmias. second-and third-degree alrioventricular (AV1 block and left bundle branch block experienced a 47% in-hospital mnrtality rate-three times that of snnilru ptuicnts without diabetes (713). Some but not all studies (47.Y7) have documented an increaSe in AV (44) and introventricular (45) conduction abnormalities in diabetic patients. Four prognostic variables in the immediate period after acute myocardial infarction in diabetic patients have been found to be independent predictors of poor prognosis. In order of descending importance they were I) Q wave acute myocardial infarction, 2) prior acute ntyocardial infarction, 3) female gender, and 4) insulin treatment before hospital admission (75). Obesity and anterior locution of inter&n are also associated with poor prognosis in diabetic patients (45).
Late Cardiac Complications and Mortality
Role of persistent teehernia. The presence of diabetes mellitus is an independent predictor of cardiac mortality, which ranges from 26% to 62% in the 1st year after myocnrdial infarction and may reach 7% by 5 years (42.45,98). Immediate postinfarction morbidity and mortality is usually due lo congestive heart failure, cardiogenic shock or eonduction disturbances. Patients survivingthese complications suffer from recurrent nonfatal (99) and fatal myocardial infarction to a greater degree than do nondiabetic patients. One explanation for the increased morbidity and mortality may be persistent ischemia or ongoing myocurdial damage after infarction. Technetium pyrophosphate scintigtaphy has been performed in diabetic and nondiabetic tatients in the acule~phase and 3 months after myocardial iufarclion (100). Sixty-two percent of diabetic patients were found to have a persistently positive technetium pyrophosphate seun at 3 months compared with only 12% of nondiabetic patients. More frequent complications after hospital discharge, ineluding congestive heart failure.recurrent myocardial infarction and death, were seen in both diabetic and nondiabetic patients with chronic technetium pyrophosphate uptake. Diabetic patients with chronic technetium pyrophosphate uptake exhibited marked myocardial myacyrolyc~s m autopsy, signifying ongoing myocardial necrosis Risk feetors for future eardiae events. As in the nondiahetic patient, certain characteristics denote patients at high risk for future cardiac events. Prognostic indicators associared wtth a poor outcome after hospital discharge at patw~ts who smvive the coronary care unit phase of ho~pitabratian include: I) cardiac symptoms for at least I month bcfure the infarction. 2) pulmonary r&s during the initial phase of the hospital stay, 3) >I0 ventricular premature heatslh heforc hospital discharge. and 41 at least moderately reduced left ventricularejection fraction (<40%) by radionuciide ventricttlography (42).
Management Considerations
Although there are few data analyzing eti?sacy of therapy in diabetic patients as a subset. there are theoretic grounds for anticipating that certain therapies may he particularly useful in the patient with diabetes. Management of the diabetic patient with acme myocardial infarction is. for the most part, similar to that of the nondiabetic pntient. wit.> certain special considerations.
Thrombolysis. Tbrombolytic therapy for myocardial infarction has proved value in patients presenting solo after the onset of infarction who demonstrate ST segment elevation on the ECG. The atypical symptoms seen m diabetic patients may not only cause delay in seeking medical care perrtttaneotts transluminZl coronaly angioplasty. Corooary artery bypass grafting is as effective in relieving angina1 rympWm5 m diabetic patients as in nondiabetic paticnt5, although the long-term survival rate after bypass surgery remains consistently lower in diabetic than in nondiabetic patients II@4 105). Diabetic patients may require more hypass grafls because of their more extensive atherosclerosis I WI. However. lam graft paRacy in these parienrs is similar to that of nondiabetic patients 1105). Perioperative mortality app+zars to be elevated in the diabetic patient-4.5% to 5.1% compared wth 2.5% in patients without diabetes (104). Poor stcrnotomy healing. renal failure and prolonged length of horpitaiization are more common in diabetic patients (104).
Percutaneous transluminal coronary angioplasty is an effective tool to relieve ischemic symptoms in diabetic patients with suitable coronary anatomy. .4ltbowb few data exist relating to coronary &iopb&on diabetics specbicatty in the acme infarction setting. it appears that diabetic patients may be somewhat more prone than nondiabetic patients t 106) to restenosis after angioplasty. Diabetes is also an independent variable predicting resteoosis after a second coronary angtoptasty ar a given site (107). In multivessel coronary angioplasty. diabetes is associated with a lower primary success rate and a hi&r rme of complications C 108). Despite possible shortcomings. coronary artery angiaplasty is an attractive treatment option due to its low morbidity and brief convalescetre period and avoidance of the potential problems associated with bypass surgery.
but make i difficult to determine the time of onset of infarction. These facton peculiar to the diabetic patient may
Secondary Prevention After Myocardial
interfere with the decision to initia!e thromholytic therapy.
Infarction
Denying treatment with a thmmbolytic agent on this basis is Beta-adrenoreeqlor block&. The "se of beta-blockers tmfonttttate because the decrease in mortality with thmmhas been shown to favorably affect mortality following bolysis in these patients is at least equal to that seen in myocardial infarction. In the Timolol in Myocardial Iafarcpatients without diabetes (101). A recent reanalysis (102) of tion study (IO!+. administration of timolol (a nonbetaprior data suggests that 1:~ bcseEt of thi;-mhcli.!ic treelment :elective agent) was associmed with a substantial reduction may be greatest in high risk subgmups such as patients with in overall mortality including total cardiac death, sudden diabetes. A high incidence of hemorrhagic complications death and nonfatal reinfarcti~n The magnitude of risk reassociated with increased mortality has been reported (I031 duction for cardiac death and nonfatal reinfarction was in diabetic patients >75 years of age. Thus. thmmholysis in particularly great in diabetic patients, suggesting an even elderly diabetic patients should probably b-e limited to those greater benefit ofbcta-blockade in this group than in patients with Me-threatening myocardial infarction until further data without diabetes. Timolol was tolerated equally well in clarify whether the benefits in this group outweigh the risks.
patients withand without diabetes. Anotherstudyexamining
Although one might presume that the presence of proliferabeta-blocker use in 281 diabetic patients after acute myocxtive retinopathy would represent B relative contraindication dial infarction found a decrease in mortality from 17% to to the use of tbmmholytic agents in many diabetic patients.
10% at I year after hospital discharge (I IO). In multivariate retinal hemorrhages were not seen in the I21 diabetic paanalysis in the same study. beta-blocker use was found to be tients treated with thromholytic agents in the Thrombolysis an independent predictor of cardiac survival at I year in and Angioplasty in Acttte Myocardial Infarction (TAMI) trial dtabetic patients, whether or not pulmonary congestion was (101). present on the admission chest X-my film. Invrvsive management. Diabetic patients with acme myo-
The potential benefits of beta-blockerr are counterbatcardial infarction who manifest signs of ongoing &hernia awed by adverse effects peculiar to the diabetic patient. despite medical therapy should be considered for myocardial These agent? may attenuate reflex tachycardia, mask "wararevasculatization by coronary artery bypass grafting or ing" symptoms due to hypoglycemia and potemiate insulininduced hypoglycemia by inhibi!ing glycogenolys~s. For these reasons. many clinicians have been reluctant to use beta-blockers in diabetic patients. On the contrary. betablockers are usually well tolerated and may be of parlicular benefit in the diabetic patient despite these concerns. Many of the complications seen with beta-blocker administration mentioned are encountered with doses higher than that which may be needed to provide secondary protection against cardiac death. Aspirin. Aspirin has sranificant moved value aiter myocardial infarction m nondiabedc p&r& reduang the r&e of short-term mortalitv and reinfarction II I I). Diabetic vatients have a height&d platelet reactivity 127-30) that I& play a role not only in the accelerated progression of atherosclerosis. but also in the development of occlusive thrombus formation at the site of coronary plaque rupture. Thus, it is likely that aspirin may be even more !xebl in patients with than in patients without diabetes because of this baseline increased platelet activity. Studies regarding primary and secondary prevention of myoeardial infarction in diabetic patients have zot been performed and would be clinically useful. Tber~ has been some concern. however, that aspirin may potentiate the develonment of retinal hemorrhage in diabetic patients. The safety-of long-term aspirin use in diabetic patients with early retinopathy has been demonstrated in the DAMAD study (I121 in which aspirin (325 mg three times daily) was administered 10 267 diabetic patients with early retinnpathy with a decrease in retinal microtmeurysms wilhout a single case of worsening retinal hemorrhage ill:!). These data may not apply to diabetic patients with rr.om severe demees of retinauathv in whom the safetv of aroirin has not yet been determ% . Risk factor modification. Attention must also focus on risk factor modification to reduce progressive athemsclerosis and the risk of reinfarction. Hypenension should he controlled. preferably wth agents tailored to improve any systolic or diastolic Icft ventricular dysfunctmn. Hyperlipidemias and obesity should be managed aggressively. Secondary prevention efforts with risk factor modification may be most justified in diabetic women who experience a particularly high late cardiac mortality rate after surviving myocardial infarction (45,77).
Cigarette smoking is an impartant factor that promotes coronary atherosclerosis. Diabetic patients are as hkely as the general public to be smokers (I 13). Cigarette smoking is an independent predictor of mortality in patients wth insulin-dependent diabetes and is particularly dangerous in diabetic women with insulin-dependent diabetes. because it more than doubles their risk of cardiac mortality (I 13).
Conclusions
Diabetes mellitus is associated with an increased morbidity and mortality related to coronary artery disease. In addition to acceleiated atherosclerosis. multiple dynamic factors related to diabetes not only predispose to acute myocardial infarction but also contribute to posrinfarctmn complications. Furlher understanding of the impact of diabetes on the pathophysiology of acute myocardial infarction may lead to more specialized treatment modalities for lhis high risk subgroup.
